European strategies for CBD to be addressed at summit
A three-tier approach to CBD regulation being advanced by the European Industrial Hemp Association (EIHA) will be reviewed during “The Future of Medical Hemp” micro-summit…
Regulatory
Hemp farmers in Portugal say 2019 growing season is lost
Some Portuguese hemp farmers say they’ll give up on the 2019 growing season due to continuing jurisdictional confusion between two government agencies over licensing. The…
Hemp extracts are firm in EU history, EIHA paper shows
The European Industrial Hemp Association (EIHA) has published a collection of historical evidence documenting the consumption hemp food and hemp food extracts in Europe to…
Case against U.S. CBD firms moves forward after some claims stripped
A federal court in New York has ruled that a racketeering and fraud case against a trio of related companies can go ahead based on…
USDA guidance clears hemp cultivation seeds for import to USA
American hemp stakeholders on Friday received clarification from the U.S. Department of Agriculture (USDA) that they can legally import hemp sowing seeds. You need to…
Euro stakeholders take a stand in Germany over ‘novel foods’
Hemp food stakeholders in Europe have taken a stand over hemp extracts in Germany after that country’s Federal Office of Consumer Protection and Food Safety…
Spanish authorities issue misguided directive on hemp extracts
The Spanish Agency for Consumer Affairs, Food Safety and Nutrition (AECOSAN) has struck a blow against hemp food producers in their ongoing efforts to clear…
Chinese govt may limit licenses in response to stock jumps
The Chinese government has tightened control on industrial hemp licenses after recent sharp fluctuations in share prices of publicly traded companies. China’s National Anti-Drug Committee…
Efforts to boost THC in EU hemp could bring results by 2021
The European Union could soon change the allowed legal THC level in approved hemp varieties from 0.2% to 0.3% after the European Parliament Committee on…
FDA warns 3 U.S. CBD sellers over ‘egregious’ cancer claims
The U.S Food & Drug Administration (FDA) and the Federal Trade Commission jointly issued warning letters to three American companies for unsubstantiated claims regarding CBD….